Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus cisplatin followed by pemetrexed consolidation therapy in japanese patients with locally advanced nonsquamous non-small-cell lung cancer

Clinical Lung Cancer

Volumn 14, Issue 1, 2013, Pages 62-69

  Niho, Seiji ^a   Kubota, Kaoru ^b   Nihei, Keiji ^b   Sekine, Ikuo ^b   Sumi, Minako ^b   Sekiguchi, Risa ^c   Funai, Jumpei ^c   Enatsu, Sotaro ^c   Ohe, Yuichiro ^a   Tamura, Tomohide ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Cisplatin; Concurrent chemoradiotherapy; Nonsquamous NSCLC; Pemetrexed

Indexed keywords

CISPLATIN; PEMETREXED; STEROID;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONSTIPATION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; ESOPHAGITIS; FEMALE; HUMAN; HYOKALEMIA; HYPOALBUMINEMIA; HYPONATREMIA; IN VITRO STUDY; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NON SQUAMOUS NON SMALL CELL LUNG CANCER; PNEUMONIA; PROTEINURIA; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SIDE EFFECT; STEROID THERAPY; THORACIC RADIOTHERAPY; VOMITING;

ADULT; AGED; ANOREXIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; CONSOLIDATION CHEMOTHERAPY; DIARRHEA; ESOPHAGITIS; FEMALE; GLUTAMATES; GUANINE; HUMANS; JAPAN; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; PNEUMONIA; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 84871588476     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.03.007     Document Type: Article

References (45)

1. A. Jemal, F. Bray, M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. J.P. Pignon, H. Tribodet, G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
3. Y. Segawa, H. Ueoka, K. Kiura A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group Br J Cancer 82 2000 104 111
4. R.O. Dillman, S.L. Seagren, K.J. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
5. R.O. Dillman, J. Herndon, S.L. Seagren Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
6. K.S. Albain, J.J. Crowley, A.T. Turrisi Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
7. P. Zatloukal, L. Petruzelka, M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung Cancer 46 2004 87 98
8. N. Hanna, M. Neubauer, C. Yiannoutsos Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 2008 5755 5760
9. W. Sause, P. Kolesar, S. Taylor IV Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364
10. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
11. W.J. Curran Jr, R. Paulus, C.J. Langer Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
12. G.A. Masters, D.J. Haraf, P.C. Hoffman Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies J Clin Oncol 16 1998 2157 2163
13. K. Kiura, H. Ueoka, Y. Segawa Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer Br J Cancer 89 2003 795 802
14. Y. Chen, P. Okunieff Radiation and third-generation chemotherapy Hematol/Oncol Clin North Am 18 2004 55 80
15. A. Aupérin, C. Le Péchoux, E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
16. H. Choy, W. Akerley, H. Safran Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer J Clin Oncol 12 1994 2682 2686
17. C. Shih, L.L. Habeck, L.G. Mendelsohn Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA) Adv Enzyme Regul 38 1998 135 152
18. R. Zhao, S. Babani, F. Gao The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate Clin Cancer Res 6 2000 3687 3695
19. S. Chattopadhyay, R.G. Moran, I.D. Goldman Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications Mol Cancer Ther 6 2007 404 417
20. L.G. Mendelsohn, C. Shih, V.J. Chen Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis Semin Oncol 26 suppl 6 1999 42 47
21. V.J. Chen, J.R. Bewley, S.L. Andis Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells Br J Cancer 78 Suppl 3 1998 27 34
22. G. Scagliotti, T. Brodowicz, F.A. Shepherd Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer J Thorac Oncol 6 2011 64 70
23. R. Zhao, F. Gao, M. Hanscom A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier Clin Cancer Res 10 2004 718 727
24. B.A. Teicher, E. Alvarez, P. Liu MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma Semin Oncol 26 suppl 6 1999 55 62
25. B.A. Teicher, V. Chen, C. Shih Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts Clin Cancer Res 6 2000 1016 1023
26. Y. Segawa, K. Kiura, N. Takigawa Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007 J Clin Oncol 28 2010 3299 3306
27. N. Yamamoto, K. Nakagawa, Y. Nishimura Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105 J Clin Oncol 28 2010 3739 3745
28. Y. Naito, K. Kubota, K. Nihei Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer J Thorac Oncol 3 2008 617 622
29. M. Machtay, C. Hsu, R. Komaki Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the radiation therapy Oncology Group (RTOG) experience Int J Radiat Oncol Biol Phys 63 2005 667 671
30. A. Brade, A. Bezjak, R. MacRae Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1395 1401
31. R. Govindan, J. Bogart, T. Stinchcombe Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: cancer and Leukemia Group B trial 30407 J Clin Oncol 29 2011 3120 3125
32. F. Cardenal, M.D. Arnaiz, T. Morán Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer Lung Cancer 74 2011 69 74
33. S.M. Gadgeel, J.C. Ruckdeschel, B.B. Patel Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer J Thorac Oncol 6 2011 927 933
34. B.S. Li, H.Y. Gong, Y. Yi Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer Am J Clin Oncol 35 2012 115 119
35. Y. Xu, S. Ma, Y. Ji Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study Lung Cancer 72 2011 327 332
36. S. Senan, D. De Ruysscher, P. Giraud Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother Oncol 71 2004 139 146
37. L.H. Sobin, C. Wittekind TNM Classification of Malignant Tumours 6th ed. 2002 Wiley-Liss New York, NY
38. G.V. Scagliotti, P. Parikh, J. von Pawel Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 2008 3543 3551
39. T. Ciuleanu, T. Brodowicz, C. Zielinski Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Lancet 374 2009 1432 1440
40. K. Kubota, S. Niho, S. Enatsu Efficacy differences of pemetrexed by histology in pretreated patients with stage IIIB/IV non-small cell lung cancer: review of results from an open-label randomized phase II study J Thorac Oncol 4 2009 1530 1536
41. M. Bischof, K.J. Weber, J. Blatter Interaction of pemetrexed disodium (Alimta, multitargeted antifolate) and irradiation in vitro Int J Radiat Oncol Biol Phys 52 2002 1381 1388
42. S. Ma, Y. Xu, Y. Ji Concomitant pemetrexed/carboplatin chemotherapy and 3D conformal radiotherapy followed by pemetrexed/carboplatin consolidation chemotherapy for locally advanced non-small cell lung cancer: preliminary results of a phase II study J Clin Oncol 28 suppl 2010 abstract 7092
43. E.E. Vokes, S. Senan, J.A. Treat PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histology Clin Lung Cancer 10 2009 193 198
44. J.H. Heinzerling, H. Choy, R.S. Hughes Toxicity and response of pemetrexed plus carboplatin or cisplatin with concurrent chest radiation therapy for patients with locally advanced non-small cell lung cancer: a phase I trial J Thorac Oncol 5 2010 1391 1396
45. M.V. Graham, J.A. Purdy, B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329